Trust Size
$57M
Peak Price
$188.80
Current Price
$15.00
Return
-88.1%
Price Journey
What Happened
Jasper Therapeutics is a clinical-stage biotechnology company developing targeted therapies for mast cell-driven diseases. The company went public via SPAC merger with Amplitude Healthcare Acquisition Corp in 2021.
Amplitude Healthcare Acquisition Corp merged with Jasper Therapeutics in 2021. The biotech company has advanced its anti-KIT antibody programs and has a price target of ~$26 from analysts. Jasper was misclassified as bankrupt and is actively trading on Nasdaq.
Timeline
2019-11-08
S-1 Registration Filed
🔀 Reverse Stock Split
Reverse split ratio: . Reverse splits are used to avoid delisting but destroy shareholder value through the illusion of a higher stock price.
SEC Filing Details
CIK Number
1788028
Total SEC Filings
431
State of Incorporation
DE
Last Filing Date
2026-02-25
Business Location
New York, NY
Trust/Asset Size
$57M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Jasper Therapeutics